CSPC PHARMACEUT.GR. ADR4 (CVGU) — Defensive Interval Ratio
CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Defensive Interval Ratio of 271 days as of December 2025. Defensive assets of €7.55 Billion (cash €-, short-term investments €2.78 Billion, receivables €4.78 Billion) cover 271 days of daily cash needs of €27.88 Million/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
CSPC PHARMACEUT.GR. ADR4 Defensive Interval Ratio (2021–2025)
This chart shows how CSPC PHARMACEUT.GR. ADR4's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 271 days, meaning defensive assets of €7.55 Billion can fund 271 days of operations without new revenue. For the complete balance sheet picture, see how large is CSPC PHARMACEUT.GR. ADR4's balance sheet.
Annual Defensive Interval Ratio for CSPC PHARMACEUT.GR. ADR4 (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for CSPC PHARMACEUT.GR. ADR4 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See CSPC PHARMACEUT.GR. ADR4 working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 271 days | €7.55 Billion | €27.88 Million/day | €- | €2.78 Billion | ▲ +20 days |
| 2024 | 251 days | €6.63 Billion | €26.39 Million/day | €- | €1.47 Billion | ▲ +2 days |
| 2023 | 249 days | €6.95 Billion | €27.90 Million/day | €- | €1.08 Billion | ▼ -57 days |
| 2022 | 306 days | €7.51 Billion | €24.54 Million/day | €- | €3.57 Billion | ▲ +66 days |
| 2021 | 240 days | €4.75 Billion | €19.80 Million/day | €- | €1.44 Billion | — |